|
G |
Adrb2 |
adrenoceptor beta 2 |
decreases response to substance |
ISO |
ADRB2 protein results in decreased susceptibility to Busulfan |
CTD |
PMID:7202579 |
|
NCBI chr18:57,513,792...57,515,834
Ensembl chr18:57,513,793...57,515,834
|
|
G |
Anp32b |
acidic nuclear phosphoprotein 32 family member B |
multiple interactions |
ISO |
[clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased cleavage of ANP32B protein |
CTD |
PMID:20933509 |
|
NCBI chr 5:62,070,709...62,094,633
Ensembl chr 5:62,071,346...62,094,633
|
|
G |
Apex1 |
apurinic/apyrimidinic endodeoxyribonuclease 1 |
increases response to substance |
ISO |
APEX1 protein mutant form results in increased susceptibility to Busulfan |
CTD |
PMID:19470598 |
|
NCBI chr15:27,849,943...27,852,083
Ensembl chr15:27,849,979...27,852,082
|
|
G |
Ar |
androgen receptor |
multiple interactions |
ISO |
Busulfan inhibits the reaction [Metribolone results in increased activity of AR protein] |
CTD |
PMID:18324785 |
|
NCBI chr X:67,656,253...67,828,998
Ensembl chr X:67,656,253...67,829,026
|
|
G |
Arhgdia |
Rho GDP dissociation inhibitor alpha |
multiple interactions affects response to substance |
ISO |
ARHGDIA mRNA affects the reaction [Busulfan results in increased activity of CASP3 protein] ARHGDIA mRNA affects the susceptibility to Busulfan |
CTD |
PMID:17264767 |
|
NCBI chr10:109,754,012...109,757,506
Ensembl chr10:109,754,004...109,757,550
|
|
G |
Atm |
ATM serine/threonine kinase |
multiple interactions |
ISO |
[clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased phosphorylation of ATM protein |
CTD |
PMID:20933509 |
|
NCBI chr 8:58,015,938...58,119,973
Ensembl chr 8:58,015,940...58,120,045
|
|
G |
Bmp4 |
bone morphogenetic protein 4 |
decreases expression |
EXP |
Busulfan results in decreased expression of BMP4 mRNA |
CTD |
PMID:15786497 |
|
NCBI chr15:20,776,060...20,791,013
Ensembl chr15:20,776,054...20,822,740
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases activity |
ISO |
[clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased cleavage of CASP3 protein; [decitabine co-treated with Busulfan] results in increased activity of CASP3 protein; ARHGDIA mRNA affects the reaction [Busulfan results in increased activity of CASP3 protein] |
CTD |
PMID:17264767 PMID:18339423 PMID:19732952 PMID:20933509 |
|
NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
|
|
G |
Casp8 |
caspase 8 |
increases activity multiple interactions |
ISO |
Busulfan results in increased activity of CASP8 protein [decitabine co-treated with Busulfan] results in increased activity of CASP8 protein; pifithrin inhibits the reaction [[decitabine co-treated with Busulfan] results in increased activity of CASP8 protein] |
CTD |
PMID:18339423 PMID:19732952 |
|
NCBI chr 9:65,614,142...65,662,624
Ensembl chr 9:65,614,142...65,662,106
|
|
G |
Casp9 |
caspase 9 |
multiple interactions |
ISO |
[clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased cleavage of CASP9 protein; pifithrin inhibits the reaction [[decitabine co-treated with Busulfan] results in increased activity of CASP9 protein] |
CTD |
PMID:19732952 PMID:20933509 |
|
NCBI chr 5:160,356,211...160,373,774
Ensembl chr 5:160,355,833...160,373,778
|
|
G |
Cdc25b |
cell division cycle 25B |
multiple interactions |
ISO |
[clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased phosphorylation of CDC25B protein |
CTD |
PMID:20933509 |
|
NCBI chr 3:123,731,539...123,741,696
Ensembl chr 3:123,731,539...123,741,339
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
decreases expression |
ISO |
Busulfan results in decreased expression of CDK2 mRNA |
CTD |
PMID:15388331 |
|
NCBI chr 7:3,124,953...3,132,533
Ensembl chr 7:3,124,954...3,132,457
|
|
G |
Cdk4 |
cyclin-dependent kinase 4 |
decreases expression |
ISO |
Busulfan results in decreased expression of CDK4 mRNA |
CTD |
PMID:15388331 |
|
NCBI chr 7:70,345,971...70,352,689
Ensembl chr 7:70,349,863...70,352,418
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression multiple interactions |
ISO |
Busulfan results in increased expression of CDKN1A protein [clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased expression of CDKN1A protein |
CTD |
PMID:16882877 PMID:20933509 |
|
NCBI chr20:6,348,422...6,358,864
Ensembl chr20:6,351,458...6,358,864
|
|
G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
increases expression |
ISO |
Busulfan results in increased expression of CDKN2A mRNA |
CTD |
PMID:14500376 |
|
NCBI chr 5:107,823,323...107,832,405
Ensembl chr 5:107,823,330...107,841,175
|
|
G |
Chek1 |
checkpoint kinase 1 |
multiple interactions |
ISO |
[clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased phosphorylation of CHEK1 protein |
CTD |
PMID:20933509 |
|
NCBI chr 8:39,181,162...39,201,588
Ensembl chr 8:39,181,163...39,243,882
|
|
G |
Chek2 |
checkpoint kinase 2 |
multiple interactions |
ISO |
[clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased phosphorylation of CHEK2 protein |
CTD |
PMID:20933509 |
|
NCBI chr12:51,845,574...51,878,098
Ensembl chr12:51,845,796...51,877,624
|
|
G |
Col4a1 |
collagen type IV alpha 1 chain |
affects expression |
ISO |
Busulfan affects the expression of COL4A1 mRNA |
CTD |
PMID:15941629 |
|
NCBI chr16:83,522,162...83,632,153
Ensembl chr16:83,522,162...83,632,153
|
|
G |
Faslg |
Fas ligand |
decreases expression |
ISO |
Busulfan results in decreased expression of FASL mRNA |
CTD |
PMID:15388331 |
|
NCBI chr13:79,696,811...79,717,581
Ensembl chr13:79,698,445...79,705,705
|
|
G |
Fgf8 |
fibroblast growth factor 8 |
decreases expression |
EXP |
Busulfan results in decreased expression of FGF8 mRNA |
CTD |
PMID:15786497 |
|
NCBI chr 1:265,492,949...265,498,965
Ensembl chr 1:265,493,124...265,498,831
|
|
G |
Gdnf |
glial cell derived neurotrophic factor |
affects expression increases expression |
ISO |
Busulfan affects the expression of GDNF mRNA Busulfan results in increased expression of GDNF mRNA |
CTD |
PMID:20684317 PMID:22082982 PMID:26524245 |
|
NCBI chr 2:56,884,181...56,912,964
Ensembl chr 2:56,887,987...56,910,238
|
|
G |
Gpx4 |
glutathione peroxidase 4 |
multiple interactions decreases expression |
ISO |
Busulfan results in decreased expression of and results in decreased activity of GPX4 protein; Deferoxamine inhibits the reaction [Busulfan results in decreased expression of GPX4 protein]; ferrostatin-1 inhibits the reaction [Busulfan results in decreased expression of and results in decreased activity of GPX4 protein]; sulforafan inhibits the reaction [Busulfan results in decreased expression of and results in decreased activity of GPX4 protein] |
CTD |
PMID:32416107 |
|
NCBI chr 7:12,516,357...12,519,154
Ensembl chr 7:12,516,352...12,519,154
|
|
G |
Gsta1 |
glutathione S-transferase alpha 1 |
multiple interactions affects response to substance affects metabolic processing affects abundance decreases response to substance |
ISO |
GSTA1 protein affects the metabolism of [Busulfan co-treated with Glutathione] GSTA1 polymorphism affects the susceptibility to Busulfan GSTA1 gene polymorphism affects the metabolism of Busulfan; GSTA1 protein affects the metabolism of Busulfan GSTA1 gene polymorphism affects the abundance of Busulfan GSTA1 protein results in decreased susceptibility to Busulfan |
CTD |
PMID:8886613 PMID:10437668 PMID:10570028 PMID:12429583 PMID:20672371 PMID:21135089 PMID:21215809 PMID:21441958 |
|
NCBI chr 9:27,366,404...27,381,004
Ensembl chr 9:27,368,272...27,452,902
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
affects metabolic processing affects abundance affects response to substance multiple interactions |
ISO |
GSTM1 protein affects the metabolism of Busulfan GSTM1 gene polymorphism affects the abundance of Busulfan GSTM1 gene polymorphism affects the susceptibility to Busulfan [GSTM1 gene polymorphism co-treated with GSTT1 gene polymorphism] affects the metabolism of Busulfan; [GSTM1 protein co-treated with CYP2C9 protein] results in increased susceptibility to [Busulfan co-treated with Cyclophosphamide] |
CTD |
PMID:8886613 PMID:15142875 PMID:19584821 PMID:20672371 PMID:21215809 PMID:28744217 |
|
NCBI chr 2:210,803,869...210,809,461
Ensembl chr 2:210,803,869...210,809,306
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
affects metabolic processing affects abundance |
ISO |
GSTP1 protein affects the metabolism of Busulfan GSTP1 gene polymorphism affects the abundance of Busulfan |
CTD |
PMID:8886613 PMID:20672371 |
|
NCBI chr 1:219,291,679...219,294,147
Ensembl chr 1:219,291,679...219,294,147
|
|
G |
Gstt1 |
glutathione S-transferase theta 1 |
multiple interactions |
ISO |
[GSTM1 gene polymorphism co-treated with GSTT1 gene polymorphism] affects the metabolism of Busulfan |
CTD |
PMID:21215809 |
|
NCBI chr20:13,799,102...13,816,527
Ensembl chr20:13,799,102...13,816,526
|
|
G |
H2ax |
H2A.X variant histone |
increases phosphorylation multiple interactions |
ISO |
Busulfan results in increased phosphorylation of H2AX protein [Clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased expression of H2AX protein |
CTD |
PMID:18339423 PMID:20933509 |
|
NCBI chr 8:48,665,652...48,666,981
Ensembl chr 8:48,665,652...48,666,981
|
|
G |
Inhba |
inhibin subunit beta A |
multiple interactions increases expression |
ISO |
bisindolylmaleimide I inhibits the reaction [Busulfan results in increased expression of INHBA mRNA]; bisindolylmaleimide I inhibits the reaction [Busulfan results in increased expression of INHBA protein] Busulfan results in increased expression of INHBA mRNA; Busulfan results in increased expression of INHBA protein |
CTD |
PMID:12966370 PMID:22286157 |
|
NCBI chr17:51,894,869...51,919,998
Ensembl chr17:51,898,217...51,912,496
|
|
G |
Kit |
KIT proto-oncogene receptor tyrosine kinase |
decreases expression |
ISO |
Busulfan results in decreased expression of KIT mRNA |
CTD |
PMID:15388331 |
|
NCBI chr14:35,072,131...35,149,638
Ensembl chr14:35,072,108...35,149,610
|
|
G |
Lama1 |
laminin subunit alpha 1 |
affects expression |
ISO |
Busulfan affects the expression of LAMA1 mRNA |
CTD |
PMID:15941629 |
|
NCBI chr 9:115,916,907...116,042,123
Ensembl chr 9:115,916,907...116,042,123
|
|
G |
Lama4 |
laminin subunit alpha 4 |
affects expression |
ISO |
Busulfan affects the expression of LAMA4 mRNA |
CTD |
PMID:15941629 |
|
NCBI chr20:44,060,715...44,201,966
Ensembl chr20:44,060,731...44,209,614
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
increases activity |
ISO |
Busulfan results in increased activity of MAPK1 protein |
CTD |
PMID:16882877 |
|
NCBI chr11:88,203,863...88,273,301
Ensembl chr11:88,211,599...88,273,254
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
increases activity |
ISO |
Busulfan results in increased activity of MAPK3 protein |
CTD |
PMID:16882877 |
|
NCBI chr 1:198,192,773...198,198,975
Ensembl chr 1:198,192,773...198,198,975
|
|
G |
Mgst2 |
microsomal glutathione S-transferase 2 |
decreases response to substance |
ISO |
MGST2 protein results in decreased susceptibility to Busulfan |
CTD |
PMID:15779864 |
|
NCBI chr 2:140,708,396...140,727,381
Ensembl chr 2:140,708,397...140,727,281
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
multiple interactions |
ISO |
[clofarabine co-treated with fludarabine co-treated with Busulfan] results in decreased expression of MYC protein |
CTD |
PMID:20933509 |
|
NCBI chr 7:102,586,313...102,591,240
Ensembl chr 7:102,586,313...102,591,240
|
|
G |
Nanos2 |
nanos C2HC-type zinc finger 2 |
decreases expression |
ISO |
Busulfan results in decreased expression of NANOS2 mRNA; Busulfan results in decreased expression of NANOS2 protein |
CTD |
PMID:26524245 |
|
NCBI chr 1:79,894,450...79,895,910
Ensembl chr 1:79,894,450...79,895,910
|
|
G |
Nanos3 |
nanos C2HC-type zinc finger 3 |
decreases expression |
ISO |
Busulfan results in decreased expression of NANOS3 mRNA |
CTD |
PMID:26524245 |
|
NCBI chr19:25,284,907...25,288,680
Ensembl chr19:25,284,909...25,288,335
|
|
G |
Nfe2l2 |
nuclear factor, erythroid 2-like 2 |
decreases expression multiple interactions |
ISO |
Busulfan results in decreased expression of NFE2L2 protein Deferoxamine inhibits the reaction [Busulfan results in decreased expression of NFE2L2 protein]; ferrostatin-1 inhibits the reaction [Busulfan results in decreased expression of NFE2L2 protein]; sulforafan inhibits the reaction [Busulfan results in decreased expression of NFE2L2 protein] |
CTD |
PMID:32416107 |
|
NCBI chr 3:62,497,568...62,525,146
Ensembl chr 3:62,497,571...62,524,996
|
|
G |
Npm1 |
nucleophosmin 1 |
multiple interactions |
ISO |
NPM1 gene mutant form results in increased susceptibility to [Busulfan co-treated with Idarubicin] |
CTD |
PMID:20172040 |
|
NCBI chr10:18,080,949...18,091,062
Ensembl chr10:18,080,950...18,090,950
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions increases cleavage |
ISO |
[clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased cleavage of PARP1 protein; [decitabine co-treated with Busulfan] results in increased cleavage of PARP1 protein; pifithrin inhibits the reaction [[decitabine co-treated with Busulfan] results in increased cleavage of PARP1 protein] Busulfan results in increased cleavage of PARP1 protein |
CTD |
PMID:18339423 PMID:19732952 PMID:20933509 |
|
NCBI chr13:98,857,255...98,889,444
Ensembl chr13:98,857,177...98,889,716
|
|
G |
Phb |
prohibitin |
affects expression |
ISO |
Busulfan affects the expression of PHB mRNA |
CTD |
PMID:15388331 |
|
NCBI chr10:83,476,107...83,488,878
Ensembl chr10:83,476,107...83,488,878
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
increases expression multiple interactions |
ISO |
Busulfan results in increased expression of PTGS2 mRNA ferrostatin-1 inhibits the reaction [Busulfan results in increased expression of PTGS2 mRNA] |
CTD |
PMID:12966370 PMID:32416107 |
|
NCBI chr13:67,351,230...67,356,920
Ensembl chr13:67,351,087...67,359,335
|
|
G |
Rad51 |
RAD51 recombinase |
decreases expression |
ISO |
Busulfan results in decreased expression of RAD51 mRNA |
CTD |
PMID:15388331 |
|
NCBI chr 3:110,918,240...110,942,920
Ensembl chr 3:110,918,243...110,942,917
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
decreases phosphorylation |
ISO |
Busulfan results in decreased phosphorylation of RB1 protein |
CTD |
PMID:15388331 |
|
NCBI chr15:55,081,582...55,209,060
Ensembl chr15:55,083,140...55,209,342
|
|
G |
Sat2 |
spermidine/spermine N1-acetyltransferase family member 2 |
increases expression |
ISO |
Busulfan results in increased expression of SAT2 mRNA; Busulfan results in increased expression of SAT2 protein |
CTD |
PMID:28578006 |
|
NCBI chr10:56,227,703...56,229,796
Ensembl chr10:56,227,692...56,229,850
|
|
G |
Serpinc1 |
serpin family C member 1 |
affects expression |
ISO |
Busulfan affects the expression of SERPINC1 protein |
CTD |
PMID:15580502 |
|
NCBI chr13:78,806,107...78,820,375
Ensembl chr13:78,805,347...78,833,192
|
|
G |
Serpine1 |
serpin family E member 1 |
increases expression multiple interactions |
ISO |
Busulfan results in increased expression of SERPINE1 mRNA; Busulfan results in increased expression of SERPINE1 protein 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Busulfan results in increased expression of SERPINE1 mRNA] |
CTD |
PMID:22286157 |
|
NCBI chr12:22,641,104...22,651,482
Ensembl chr12:22,641,104...22,651,482
|
|
G |
Slc40a1 |
solute carrier family 40 member 1 |
decreases expression multiple interactions |
ISO |
Busulfan results in decreased expression of SLC40A1 protein Deferoxamine inhibits the reaction [Busulfan results in decreased expression of SLC40A1 protein]; ferrostatin-1 inhibits the reaction [Busulfan results in decreased expression of SLC40A1 protein]; sulforafan inhibits the reaction [Busulfan results in decreased expression of SLC40A1 protein] |
CTD |
PMID:32416107 |
|
NCBI chr 9:52,819,451...52,830,461
Ensembl chr 9:52,894,365...52,912,293
|
|
G |
Smc1a |
structural maintenance of chromosomes 1A |
multiple interactions |
ISO |
[clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased phosphorylation of SMC1A protein |
CTD |
PMID:20933509 |
|
NCBI chr X:21,710,976...21,755,708
Ensembl chr X:21,711,019...21,755,525
|
|
G |
Smc3 |
structural maintenance of chromosomes 3 |
multiple interactions |
ISO |
[clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased phosphorylation of SMC3 protein |
CTD |
PMID:20933509 |
|
NCBI chr 1:274,310,120...274,352,856
Ensembl chr 1:274,309,758...274,352,854
|
|
G |
Stra8 |
stimulated by retinoic acid 8 |
decreases expression |
ISO |
Busulfan results in decreased expression of STRA8 mRNA |
CTD |
PMID:15388331 |
|
NCBI chr 4:62,447,724...62,474,802
Ensembl chr 4:62,457,694...62,473,360
|
|
G |
Tf |
transferrin |
multiple interactions increases expression |
ISO |
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Busulfan results in increased expression of TF mRNA] Busulfan results in increased expression of TF mRNA; Busulfan results in increased expression of TF protein |
CTD |
PMID:12966370 PMID:22286157 |
|
NCBI chr 8:111,694,570...111,721,275
Ensembl chr 8:111,673,547...111,721,333
|
|
G |
Tfpi |
tissue factor pathway inhibitor |
decreases expression |
ISO |
Busulfan results in decreased expression of TFPI mRNA |
CTD |
PMID:22286157 |
|
NCBI chr 3:71,852,738...71,902,127
Ensembl chr 3:71,852,744...71,893,618
|
|
G |
Tfrc |
transferrin receptor |
decreases expression multiple interactions |
ISO |
Busulfan results in decreased expression of TFRC protein Deferoxamine promotes the reaction [Busulfan results in decreased expression of TFRC protein] |
CTD |
PMID:32416107 |
|
NCBI chr11:71,397,423...71,419,263
Ensembl chr11:71,397,383...71,419,223
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
increases expression |
ISO |
Busulfan results in increased expression of TGFB1 mRNA |
CTD |
PMID:22286157 |
|
NCBI chr 1:82,480,875...82,497,196
Ensembl chr 1:82,480,195...82,497,199
|
|
G |
Thbs1 |
thrombospondin 1 |
increases expression |
ISO |
Busulfan results in increased expression of THBS1 mRNA |
CTD |
PMID:22286157 |
|
NCBI chr 3:109,862,120...109,873,466
Ensembl chr 3:109,862,117...109,873,466
|
|
G |
Tnf |
tumor necrosis factor |
increases expression |
ISO |
Busulfan results in increased expression of TNF mRNA |
CTD |
PMID:22286157 |
|
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions |
ISO |
Busulfan affects the phosphorylation of and affects the activity of TP53 protein |
CTD |
PMID:16882877 |
|
NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
|
|
G |
Txnrd1 |
thioredoxin reductase 1 |
decreases activity |
EXP |
Busulfan results in decreased activity of TXNRD1 protein |
CTD |
PMID:16085187 |
|
NCBI chr 7:26,946,124...26,984,400
Ensembl chr 7:26,946,125...26,984,400
|
|
G |
Xiap |
X-linked inhibitor of apoptosis |
multiple interactions |
ISO |
[clofarabine co-treated with fludarabine co-treated with Busulfan] results in decreased expression of XIAP protein |
CTD |
PMID:20933509 |
|
NCBI chr X:128,409,425...128,455,786
Ensembl chr X:128,409,472...128,453,000
|
|
G |
Zbtb16 |
zinc finger and BTB domain containing 16 |
increases expression |
ISO |
Busulfan results in increased expression of ZBTB16 mRNA |
CTD |
PMID:26524245 |
|
NCBI chr 8:52,980,226...53,146,765
Ensembl chr 8:52,985,313...53,146,953
|
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases expression |
EXP |
Diflubenzuron results in increased expression of CYP1A1 protein |
CTD |
PMID:8812189 |
|
NCBI chr 8:62,472,087...62,478,122
Ensembl chr 8:62,472,095...62,478,147
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
affects binding |
ISO |
Diflubenzuron binds to CYP1A2 protein |
CTD |
PMID:32278787 |
|
NCBI chr 8:62,451,360...62,458,244
Ensembl chr 8:62,451,329...62,458,301
|
|
G |
Cyp3a23-3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1 |
increases expression |
EXP |
Diflubenzuron results in increased expression of CYP3A23-3A1 protein |
CTD |
PMID:8812189 |
|
NCBI chr12:11,053,888...11,082,742
Ensembl chr12:11,655,402...11,733,136
|
|
G |
Cyp3a62 |
cytochrome P450, family 3, subfamily a, polypeptide 62 |
affects binding |
ISO |
Diflubenzuron binds to CYP3A4 protein |
CTD |
PMID:32278787 |
|
NCBI chr12:18,679,809...18,709,397
Ensembl chr12:18,678,594...18,709,397
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
increases activity |
ISO |
Diflubenzuron results in increased activity of NR1I2 protein |
CTD |
PMID:16565514 |
|
NCBI chr11:65,022,100...65,058,546
Ensembl chr11:65,022,100...65,058,545
|
|